In this study, we aim to characterize the stress response to a visual field exam performed as part of a standard ophthalmology visit with the use of biometric devices, a standardized anxiety inventory, and measurement of salivary cortisol before and after the test. We further aim to assess how stress responses vary depending on the length of time required to complete testing as well as variability...
The primary objective of the study is to investigate the safety and efficacy of KPI-012 compared to vehicle in participants who have a documented clinical diagnosis of PCED
The objective of this study is to evaluate disease progression, using multiple modalities, in subjects with genetically-confirmed STGD1.
To evaluate the efficacy of batoclimab 680 mg subcutaneously (SC) once a week (QW) for 12 weeks followed by 340 mg SC QW for 12 weeks versus placebo on proptosis responder rate at Week 24
An Open-label Extension Study for Participants who Completed Study IMVT-1401-3201 or Study IMVT-1401-3202 to Assess the Efficacy and Safety of Batoclimab for the Treatment of Thyroid Eye Disease (TED)
